Yasunori Yokogawa

Title: Yasunori Yokogawa: Innovator in Biopharmaceuticals

Introduction

Yasunori Yokogawa is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of polypeptides and antimycotic agents. With a total of 3 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Yokogawa's latest patents include a physiologically active polypeptide known as BUF-3. This polypeptide has the ability to differentiate and mature human leukemia cells into normal cells, thereby accelerating the formation of erythroblasts. The molecular weight of BUF-3 is determined to be 16 ± 1 Kd in the presence of 1% mercaptoethanol, or 25 ± 1 Kd in its absence. Another notable patent is for a heptaene V-28-3 antibiotic derivative, which serves as an antimycotic agent. This compound exhibits a high degree of antimicrobial activity towards Eumycetes while maintaining a lower level of toxicity compared to the original heptaene antibiotic V-28-3.

Career Highlights

Throughout his career, Yokogawa has worked with notable companies, including Ajinomoto Co., Ltd. His innovative research has positioned him as a key figure in the biopharmaceutical industry.

Collaborations

Yokogawa has collaborated with esteemed colleagues such as Hiroshiro Shibai and Yuzuru Eto. Their combined expertise has contributed to the advancement of research in their respective fields.

Conclusion

Yasunori Yokogawa's contributions to biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.